• Filter By:
• Specialty
• Source
• Condition
• Cancer
• Infectious Disease
• Drug
• Training
• Management
• Procedure
• Therapy
• Vaccine
• Nutrition
• Country

The number of valvular insufficiency is a strong predictor of cardiovascular and all-cause mortality in hemodialysis patients
ConclusionsIn maintenance HD patients, the prevalence of VI is prominently high. The number of VI  ≥ 2 is associated with emergency hospitalized for acute heart failure, cardiovascular and all-cause mortality. Combining age, number of VI ≥ 2, and albumin can predict cardiovascular and all-cause mortality.
Source: International Urology and Nephrology - April 3, 2023 Category: Urology & Nephrology Source Type: research

Clinical outcomes of stroke in hemodialysis patients: a retrospective single-center study
ConclusionsStroke outcome in these patients is dismal with prolonged hospital stay, poor functional status at discharge, very limited response to rehabilitation, and increased mortality.
Source: International Urology and Nephrology - June 30, 2019 Category: Urology & Nephrology Source Type: research

Significant association of anti-platelet factor 4/heparin antibody with cardiovascular disease in hemodialysis patients: a longitudinal 7-year study
ConclusionThis study reveals that PF4-H Ab is a risk factor for developing CAD, IS, and AVFT among hemodialysis patients.
Source: International Urology and Nephrology - October 15, 2018 Category: Urology & Nephrology Source Type: research

Decreased percentage of peripheral na ïve T cells is independently associated with ischemic stroke in patients on hemodialysis
ConclusionA decrease in percentage of peripheral CD4 na ïve T cells is a risk factor for ischemic stroke in patients on hemodialysis.
Source: International Urology and Nephrology - September 15, 2017 Category: Urology & Nephrology Source Type: research

Dry weight assessment by combined ultrasound and bioimpedance monitoring in low cardiovascular risk hemodialysis patients: a randomized controlled trial
ConclusionsThis study shows that a LUS –bioimpedance-guided dry weight adjustment protocol, as compared to clinical evaluation, does not reduce all-cause mortality and/or CVE in HD patients. A fluid management protocol based on bioimpedance with LUS on indication might be a better strategy.
Source: International Urology and Nephrology - December 6, 2016 Category: Urology & Nephrology Source Type: research

Impact of dialysis modality on the survival of patients with end-stage renal disease and prior stroke
Conclusions PD was associated with overall poorer survival among patients with diabetes, ESRD and prior stroke and with similar overall survival among patients with ESRD and prior stroke, but without diabetes, compared with HD.
Source: International Urology and Nephrology - November 11, 2015 Category: Urology & Nephrology Source Type: research

Risk-based individualisation of target haemoglobin in haemodialysis patients with renal anaemia in the post-TREAT era: theoretical attitudes versus actual practice patterns (MONITOR-CKD5 study)
Conclusions Physicians’ theoretical attitudes to anaemia management in patients on haemodialysis appear to have been influenced by the results of the TREAT study, which involved patients not on dialysis. Physicians claim to use risk-based target Hb levels to guide renal anaemia care. However, there is discrepancy between these declared risk-based target Hb levels and actual target Hb levels for patients with variable risk factors.
Source: International Urology and Nephrology - April 17, 2015 Category: Urology & Nephrology Source Type: research